Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

Julian G Hurdle1, Alex J O'Neill, Ian Chopra

  • 1Department of Biology, University of Texas at Arlington, Arlington, Texas 76019, USA. hurdle@uta.edu

Insights

Treating persistent bacterial infections requires new antibiotics. Disrupting bacterial membranes offers a promising strategy against dormant, non-growing bacteria, leading to new antimicrobial development.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Persistent bacterial infections are difficult to treat with conventional antibiotics targeting growing cells.
  • Dormant or slow-growing bacteria evade current therapies, necessitating novel antimicrobial approaches.
  • Bacterial membrane integrity and function are crucial for survival, even in non-growing states.

Purpose of the Study:

  • To review emerging strategies for targeting dormant bacteria in persistent infections.
  • To explore the potential of disrupting bacterial membrane function as a therapeutic approach.
  • To highlight the clinical relevance of membrane-active agents against recalcitrant bacteria.

Main Methods:

  • Review of current literature on persistent infections and antimicrobial resistance.
  • Analysis of mechanisms of action for membrane-targeting agents.
  • Evaluation of clinical data for exemplified therapies like lipoglycopeptides and TMC207.

Main Results:

  • Disrupting the bacterial membrane bilayer or integral membrane proteins is a viable strategy against dormant bacteria.
  • Membrane-active agents, such as lipoglycopeptides and diarylquinoline TMC207, show efficacy in treating persistent infections.
  • These agents target essential membrane functions like potential and energy metabolism in non-growing bacteria.

Conclusions:

  • Membrane-active agents represent a significant advancement in combating persistent bacterial infections.
  • Targeting bacterial membranes offers a new therapeutic avenue for eradicating dormant and recalcitrant bacteria.
  • Further development of these agents is crucial for addressing unmet needs in infectious disease treatment.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...